Form 8-K - Current report:
SEC Accession No. 0000950170-25-105474
Filing Date
2025-08-08
Accepted
2025-08-08 07:45:30
Documents
12
Period of Report
2025-08-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hrtx-20250808.htm   iXBRL 8-K 83313
2 EX-99.1 hrtx-ex99_1.htm EX-99.1 400724
3 EX-99.2 hrtx-ex99_2.htm EX-99.2 38410
  Complete submission text file 0000950170-25-105474.txt   695778

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hrtx-20250808.xsd EX-101.SCH 49738
14 EXTRACTED XBRL INSTANCE DOCUMENT hrtx-20250808_htm.xml XML 4711
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 251196218
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)